NOTICE OF CLOSURE OF TRADING WINDOW FOR THE QUARTER ENDED 30TH JUNE 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Ltd has announced the closure of its trading window for the quarter ended 30th June 2025, in compliance with SEBI's insider trading regulations. During this period, designated persons including directors, key managerial personnel, and connected employees are prohibited from buying, selling, or dealing in the company's shares. The closure typically begins shortly before the scheduled board meeting to approve the unaudited financial results for the quarter. The trading window will reopen 48 hours after the results are publicly disclosed.
This is a routine compliance announcement and not indicative of any material event. It signals that the company's Q1 FY26 financial results are likely due soon, and shareholders should expect the results announcement in the near term.